PharmaCielo (PCLOF) AI Stock Analysis

Top Page

PharmaCielo

(Other OTC:PCLOF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue GrowthThe sharp TTM revenue rebound indicates stronger recent demand for the company’s products and improved commercial traction. If maintained, higher sales can provide operating leverage, support broader customer penetration, and create a foundation for eventual profitability.

Negative Factors

Persistent UnprofitabilityContinued substantial losses show that the company has not yet scaled its revenue base enough to cover operating costs. Without a sustained reduction in losses, growth may require additional funding and the improved margin profile may not translate into durable shareholder value.

PharmaCielo (PCLOF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $8.01M
Dividend Yield: ―
Average Volume (3M): 23.99K
Price to Earnings (P/E): -2.7
Beta (1Y): -1.80
Revenue Growth: 1.65%
EPS Growth: 57.28%
Country: US
Employees: 268
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

PharmaCielo Business Overview & Revenue Model

Company Description

PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medici...

PharmaCielo Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

PCLOF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:INNO	56Neutral	CAD 8.55M	-6.55	-19.37%	―	-19.20%	42.54%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:LABS	49Neutral	CAD 27.77M	-5.60	-13.79%	―	-6.74%	43.54%
TSE:OILS	45Neutral	CAD 3.40M	-1.75	-43.92%	―	-18.30%	-397.37%
TSE:ATLE	42Neutral	CAD 41.96M	-0.76	-2099.75%	―	-100.00%	94.43%
TSE:AVCN	41Neutral	CAD 14.11M	-3.24	-108.44%	―	-0.23%	-142.54%

* Healthcare Sector Average

Performance Comparison

PCLOF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
PCLOF	Pharmacielo	0.04	0.01	39.29%
TSE:ATLE	Willow Biosciences	0.09	-0.07	-43.75%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-13.33%
TSE:OILS	Nextleaf Solutions	0.02	-0.04	-66.67%
TSE:AVCN	Avicanna Inc	0.10	-0.16	-60.38%
TSE:INNO	Innocan Pharma Corporation	1.90	-16.10	-89.44%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

PharmaCielo AI Stock Analysis